secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRA LIFESCIENCES HOLDINGS CORP (IART)
CIK:        0000917520
Form:       8-K
Filed at:   2024-02-28T23:59:59+00:00
Accession:  0000917520-24-000018
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integra LifeSciences CEO Jan De Witte to retire by end of 2024; Stuart Essig named Executive Chairman
--------------------------------------------------------------------------------

- Jan De Witte to retire as President and CEO by end of 2024 after successor appointed; will remain until transition.
- Stuart Essig, current Chairman, appointed Executive Chairman effective immediately to lead transition.
- Board engaged Heidrick & Struggles to search for new CEO candidate; expects to appoint successor by end of 2024.
- De Witte to serve as Senior Advisor from transition date through March 2026 under consulting agreement with base salary and bonus eligibility.
- De Witte's retirement is for personal reasons, not due to disagreement with company operations or policies.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/917520/000091752024000018/0000917520-24-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/917520/000091752024000018/iart-20240227.htm
  HTML page:      https://secwatch.observer/filing/0000917520-24-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer